New research presented at EASD has linked infant formula and the early introduction of fizzy drinks with higher levels of body fat later in childhood. Youngsters who were breastfed for at least ...
Severe hypoglycaemia is more than twice as common among adults with diabetes who struggle to afford food, new research presented at EASD has found. Severe hypoglycaemia occurs when a ...
A global leader in real-time continuous glucose monitoring (CGM) for people with diabetes has announced new clinical study outcomes that further demonstrate the benefits of CGM use. At the 59th ...
For pregnant women with type 1 diabetes, a technology giving insulin doses, as informed by a smartphone algorithm, helps them better manage their blood sugars compared with traditional insulin ...
New research reveals a marked increase in several common conditions in the years leading up to, and immediately prior to, type 2 diabetes diagnosis, suggesting considerably earlier diagnosis ...
New research presented at EASD has identified a range of characteristics associated with a higher risk of sudden cardiac arrest in individuals with type 2 diabetes. These include some commonly ...
Tirzepatide is as effective at treating early-onset type 2 diabetes as it is at treating type 2 diabetes diagnosed later in life, new research presented at EASD has found. Tirzepatide belongs to ...
The possibility of universal screening for type 1 diabetes was the theme of a session at this year’s EASD annual meeting in Hamburg, Germany. The talk was given by Dr Emily K. Sims, ...
Six adults with type 1 diabetes treated with stem cell-derived islet cells have shown improved blood sugar control, with three participants achieving insulin independence. This is according to ...
New research presented at this year’s EASD meeting shows that semaglutide significantly improves blood sugar control and weight loss in adults with type 2 diabetes for up to three years. ...